Product Specifications
| Form | Tablet |
| Strength | 100 mg / 150 mg |
| Treatment | Non-small cell lung cancer and Pancreatic cancer |
| Shelf life | 2 years |
| Composition | Erlotinib |
| Manufacturer | Glenmark |
| Packaging Size | 30 Tablets |
| Prescription/Non prescription | Prescription |
Product Description
Erleva Erlotinib tablets, 100mg/150mg strength, indicated for non-small cell lung and pancreatic cancer. Each pack contains 30 tablets with a 2-year shelf life. Prescription required.